Paul Sekhri Joins Topas Therapeutics as Chairman of the Board
April 4, 2017
Hamburg, April 4, 2017 – Topas Therapeutics GmbH (“Topas”), a privately held biotech company pursuing a novel liver-based immune tolerance approach, today announced the election